PHRX (Pharmagen) Common Stock: $0.51 Mil (As of Mar. 2014)


What is Pharmagen Common Stock?

Pharmagen PHRX -90.00% Common Stock is $0.51 Mil as of Mar. 2014.

Pharmagen's quarterly common stock increased from Sep. 2013 ($0.37 Mil) to Dec. 2013 ($0.43 Mil) and increased from Dec. 2013 ($0.43 Mil) to Mar. 2014 ($0.51 Mil).

Pharmagen's annual common stock increased from Jun. 2011 ($0.01 Mil) to Dec. 2012 ($0.38 Mil) and increased from Dec. 2012 ($0.38 Mil) to Dec. 2013 ($0.43 Mil).

Pharmagen Common Stock Historical Data

* Premium members only.

The historical data trend for Pharmagen's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagen Common Stock Chart

Pharmagen Annual Data
Trend Jun10 Jun11 Dec12 Dec13
Common Stock
0.01 0.01 0.38 0.43

Pharmagen Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.39 0.37 0.43 0.51

Pharmagen Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.51 Mil mean?
Pharmagen (PHRX) has a Common Stock of $0.51 Mil as of Mar. 2014. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Pharmagen and its competitors.
Is Pharmagen's Common Stock too high?
Pharmagen's current Common Stock is $0.51 Mil.
How does Pharmagen's Common Stock compare to FZMD and SNYR?
Pharmagen's Common Stock of $0.51 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Distribution company?
A good Common Stock depends on the Medical Distribution industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Pharmagen and its competitors. Pharmagen's current Common Stock is $0.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagen stock overvalued right now?
Pharmagen (PHRX) has a current Common Stock of $0.51 Mil. The current Common Stock is $0.51 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Pharmagen (PHRX), the current Common Stock is $0.51 Mil as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagen Business Description

Address 9337 Fraser Avenue, Silver Spring, MD, USA, 20910
Pharmagen Inc as a distributor of specialty drugs, compounding and admix pharmacy, and producer of over-the-counter branded multivitamins to the healthcare provider market. The company distributes hard-to-find and specialty drugs to the healthcare provider market throughout the United States, while functioning as an aggregator of real-time market demand for these products.